References
- Briggs D, Welsh KJ. Major histocompatibility complex class II genes and systemic sclerosis. Ann Rheum Dis 1991;50:862–5.
- Czirjac L, Danko K, Schlamimadinger J, Suranyi P, Tamasi L, Szegedi GY. Progressive systemic sclerosis occuring in patients exposed chemicals. Int J Dermatol 1987;26:374–8.
- Silman AJ, Newman J. Epidemiology of systemic sclerosis. Curr Opin Rheum 1996;8:585–9.
- Kasukawa R, Tojo T, Miyawaki S, Yoshida H, Tanimato K, Nobunaga, et al. Diagnosis of mixed connective tissue disease: preliminary diagnostic criteria for classification of mixed connec-tive tissue disease. In: Kasukawa R, Sharp GC, editors. Mixed connective tissue disease and anti-nuclear antibodies. Amsterdam: Elsevier; 1987. p. 41–8.
- Stephens CO, Briggs DC, Whyte J, Artlett CM, Scherbakov AB, Olsen N, et al. Familial scleroderma. Evidence for Renvironmental versus genetic trigger.
- Lynch CJ, Singh G, Whiteside TL, Rodnan GP, Medsger TA Jr, Rabin BS. Histocompatibility antigens in progressive systemic scle-rosis (scleroderma). J Ftheumatol 1982;2:314–8.
- Gladman DD, Keystone EC, Baron M, Lee P, Cane D, Mervert H. Increased frequency of DR5 in scleroderma. Arthritis Rheum 1981;24:854–6.
- Kallenberg CGM, Van der Voot-Beelen JM, D'Amaro J, The TH. Increased frequency of B8/DR3 in scleroderma and association of haplotype with impaired cellular response. Clin Exp Immunol 1981;43:478–5.
- Black CM, Welsh KI, Maddison PJ, Jayson MIV, Bernstein RM. HLA antigens, autoantibodies and clinical subsets of scleroderma. Br J Ftheumatol 1984;23:267–71.
- Hietarinta M, Bone J, Lassila O, Hieta harju A. Association of HLA antigens with anti-Scl 70 antibodies and clinical manifesta-tions of systemic sclerosis (scleroderma). Br J Ftheumatol 1994;33: 323–6.
- Kondo H, Yoshii M, Kashiwazaki S, Kashiwagi N. Histocompat-ibility antigens in progressive systemic sclerosis. In: Black CM, Myers AR, editors. Systemic sclerosis (scleroderma). New York: Gower Medical; 1985. p. 97–101.
- Jazwinska EC, Olive C, Dunckley H, Naitos S, Kuseba T, Serjeantson SW. HLA-Dw15 is increased in frequency in Japanese scleroderma patients. Dis Markers 1991;8:323–6.
- Takeuchi F, Nalkano K, Yamada H, Hong GH, Nabata H, Yoshida A, et al. Association of HLA-DR with HLA-DR in Japanese. J Ftheumatol 1994;21:857–63.
- Satoh M, Akizuki M, Kuwana M, Mimori T, Yamagata H, Yoshida S, et al. Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma. J Ftheumatol 1994;21:111–4.
- Arnett FC, Howard RB, Tan F, Moulds JM, Bias WB, Durban E, et al. Increased prevalence of systemic sclerosis in a Native Ameri-can tribe in Oklahoma. Arthritis Rheum 1996;39:1362–70.
- Tan FK, Stivers DN, Foster MW, Chakreborty R, Howard FtF, Milewicz DM, et al. Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with sdero-derma in a native American population. Arthritis Rheum 1998;41: 1729–37.
- Kuwana M, Okano Y, Kaburaki J, Inoko H. HLA class II genes associated with anticentromera antibody in Japanese patients with systemic sclerosis (scleroderma). Ann Rheum Dis 1995;54: 983–7.